4.5 Article

Trabectedin as a New Chemotherapy Option in the Treatment of Relapsed Platinum Sensitive Ovarian Cancer

Journal

CURRENT PHARMACEUTICAL DESIGN
Volume 18, Issue 25, Pages 3754-3769

Publisher

Bentham Science Publishers Ltd.
DOI: 10.2174/138161212802002814

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available